As Tylenol Lawsuits Mount, Bernstein Liebhard LLP Comments on New Analysis Questioning Labeling Standards for Over-The-Counter Acetaminophen Products

The Firm is evaluating Tylenol lawsuits on behalf of individuals who sustained severe liver damage, allegedly due to the acetaminophen in Tylenol-brand over-the-counter medications.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInShare on PinterestEmail a friend
Free Case Review
Scores of Tylenol lawsuits are currently pending in U.S. courts that allege the acetaminophen contained in these products caused patients to suffer serious liver injuries.

New York, New York (PRWEB) August 25, 2014

As Tylenol lawsuits (http://www.tylenollawsuitcenter.com/) continue to mount in federal court, Bernstein Liebhard LLP notes the publication of a new analysis by Consumer Reports that raises questions about the labeling standards for over-the-counter acetaminophen products. Among other things, Consumer Reports found that because federal health regulators seem to be more focused on prescription painkillers, labeling for over-the-counter medications containing acetaminophen is extremely inconsistent. For example, while some manufacturers set maximum daily dosage at 1,000 mg per day, labeling for other products suggests that up to four times as much can be taken safely. *

“Scores of Tylenol lawsuits are currently pending in U.S. courts that allege the acetaminophen contained in these products caused patients to suffer serious liver injuries. Among other things, plaintiffs claim that Tylenol’s labeling did not provide adequate warnings about the association between acetaminophen and liver damage,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is offering free legal reviews to consumers who allegedly suffered acetaminophen-induced liver damage resulting in hospitalization, liver transplantation, or death after ingesting a Tylenol product.*

Tylenol Liver Damage Allegations
Court documents indicate that at least 150 Tylenol lawsuits involving liver damage allegations have been filed in a federal multidistrict litigation underway in U.S. District Court, Eastern District of Pennsylvania. Among other things, the claims allege that individuals who used these medication suffered severe liver damage resulting in hospitalization, liver transplantation, or death, even when the products were used in accordance with label directions. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)

The Philadelphia Inquirer recently reported that 78,000 people require emergency room care every year due to toxic reactions to acetaminophen. Such injuries also result in about 33,000 hospitalizations every year.** In 2011, the U.S. Food & Drug Administration (FDA) announced that it would limit the amount of acetaminophen in prescription medications to 325 mg per tablet.

The FDA has not imposed similar limits on the amount of acetaminophen in over-the-counter products. In August 2013, Bloomberg.com reported that over-the-counter Extra Strength Tylenol caplets each contain 500 mg of acetaminophen, well over the new limits for prescription medications set by the FDA. That same month, McNeil Consumer Healthcare announced that it would add new, more prominent warnings regarding the risk of liver damage to the labels of Tylenol-brand medication.***

Individuals who suffered serious liver injuries allegedly related to the acetaminophen in Tylenol products may be entitled to compensation for their injury-related damages. To learn more about filing a Tylenol lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free legal review, please call 800-511-5092.

*consumerreports.org/cro/magazine/2014/09/the-dangers-of-painkillers/index.htm, Consumer Reports, July 2014
**articles.philly.com/2014-02-17/news/47382323_1_acetaminophen-poisoning-tylenol-maker-kate-trunk, Philadelphia Inquirer, February 17, 2014
***bloomberg.com/news/2013-08-29/j-j-adds-warning-to-tylenol-caps-on-acetaminophen-risk.html, Bloomberg.com, August 29, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.tylenollawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author